Skip to main content

Advertisement

Log in

Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

This study was conducted to compare the efficacy of intravenous diphenhydramine with dihydroergotamine mesylate (DHE-45; Novartis International AG, Switzerland) in the treatment of severe, refractory, migraine headache. A retrospective review was conducted to include eighty randomly chosen patients who were admitted to the Michigan Head Pain & Neurological Institute’s inpatient program at Chelsea Community Hospital. Patients had received nine doses of diphenhydramine or nine doses of DHE-45 during a 3-day period. Patients receiving DHE-45 also received metoclopramide (Reglan; AH Robins Company, Inc., Richmond, VA) as prophylaxis for nausea. Demographics, headache diagnosis, psychiatric discharge diagnoses, abortive medications, and adverse events were recorded and assessed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Saper, Joel R, Hamel R, et al.: Handbook of Headache Management: A Practical Guide to Diagnosis and Treatment of Head, Neck, and Facial Pain. Baltimore: Lippincott Williams & Wilkins; 1999. This handbook is a great review of the pathophysiology of migraine. The authors review the various neurotransmitters involved in migraine pathogenesis and practical treatment guidelines for nonheadache clinicians.

    Google Scholar 

  2. Raskin N, Callahan M: A controlled study of DHE-45 in the treatment of acute migraine headache. Headache 1986, 26:168–171.

    Article  PubMed  Google Scholar 

  3. Young WB: Appropriate use of ergotamine tartrate and DHE-45 in the treatment of migraine: current perspectives. Headache 1997, 37(suppl 1):S42-S45.

    PubMed  Google Scholar 

  4. Swidan S, Hamel R, Saper J, et al.: The efficacy of IV diphenhydramine vs. dihydroergotamine, ketorolac, chlorpromazine, and droperidol in the treatment of refractory daily chronic headache [Abstract]. Neurology 1999, 52(suppl 2):A255-A256.

    Google Scholar 

  5. Mansfield LE: The role of antihistamine therapy in vascular headaches. J Allergy Clin Immunol 1990, 86:673–676. Various studies have linked the role of histamine to cluster and migraine headaches. Thus far, it is unclear which neurotransmitter interplay seems more critical in provoking headaches in prone patients. Recent studies demonstrated that various histamine receptors exist and various receptor conformations may be a useful guide to future drug development targeting these receptors. Further studies of H3 histamine receptors, which indicate that H3 agonists offer promise as prophylactic agents for people who suffer from headaches are warranted.

    Article  PubMed  CAS  Google Scholar 

  6. Anthony M, Lord GD, Lance JW: Controlled trials of cimetidine in migraine and cluster headache. Headache 1978, 18:261–264.

    Article  PubMed  CAS  Google Scholar 

  7. Somerville BW: Treatment of migraine attacks with an analgesic combination (mersyndol). Med J Aust 1976, 1:865–866.

    PubMed  CAS  Google Scholar 

  8. Lane PL, McLellan BA, Baggoley CJ: Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med 1989, 18:360–365.

    Article  PubMed  CAS  Google Scholar 

  9. Thomsen LL, Olesen J: A pivotal role of nitric oxide in migraine pain. Ann NY Acad Sci 1997, 835:363–372.

    Article  PubMed  CAS  Google Scholar 

  10. Thomsen LL: Investigations into the role of nitric oxide and the large intracranial arteries in migraine headache. Cephalalgia 1997, 17:873–893.

    Article  PubMed  CAS  Google Scholar 

  11. Olesen J, Thomsen LL, Lassen LH, et al.: The nitric oxide hypothesis of migraine and other vascular headaches. Cephalalgia 1995, 15:94–100.

    Article  PubMed  CAS  Google Scholar 

  12. Lassen LH, Thomsen LL, Kruuse C, et al.: Histamine-1 receptor blockade does not prevent nitroglycerin induced migraine. Eur J Clin Pharmacol 1996, 49:335–339.

    Article  PubMed  CAS  Google Scholar 

  13. Welch KM: Pathogenesis of migraine. Sem Neurol 1997, 17:335–341. This article reviews the complex interplay of the various neurotransmitters for the mechanism of headache. Models of aura mechanisms include transient cerebral ischemia and spreading depression also are reviewed. It has been shown by various publications thus far that migraine attacks are caused by various malfunctions that involve the trigeminovascular system and brain stem. The trigger of a migraine attack depends on various factors such as threshold of brain excitability. Mitochondrial disorder, magnesium deficiency, and abnormality of presynaptic calcium channels.

    Article  CAS  Google Scholar 

  14. Ottosson A, Edvinsson L: Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide and effect of sumatriptan. In Headache Pathogenesis: Monoamines, Neuropeptides, Purines, and Nitric Oxide. Edited by Olesen J, Edvinsson L. Philadelphia: Lippincott-Raven; 1997:167–171.

    Google Scholar 

  15. Heatley RV, Denburg JA, Bayer N, et al.: Increased plasma histamine levels in migraine patients. Clin Allergy 1982, 12:145–149.

    Article  PubMed  CAS  Google Scholar 

  16. Lipton RB: Ergotamine tartrate and DHE-45 mesylate: safety profiles. Headache 1997, 37(suppl 1):S33-S41.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Swidan, S.Z., Lake, A.E. & Saper, J.R. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache. Current Science Inc 9, 65–70 (2005). https://doi.org/10.1007/s11916-005-0077-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-005-0077-5

Keywords

Navigation